VentaProst Versus Conventionally-Administered Aerosolized Epoprostenol in Patients Undergoing Cardiac Surgery With CPB

NCT03122730 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Hypertension

Interventions

COMBINATION_PRODUCT: VentaProst

Sponsor

Aerogen Pharma Limited